Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.39
Price to sales ratio
23.48

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4631
LPCN
Lipocine Inc. - Common Stock
2.31 USD-1.70%-3.35%+0.87%-20.34%19.04 M USD
4649
ALLR
Allarity Therapeutics, Inc. - Common stock
1.16 USD+2.65%+2.65%-20.00%+16.00%18.46 M USD
4658
KALA
KALA BIO, Inc. - Common Stock
0.96 USD-11.93%-36.42%-64.18%-82.70%17.85 M USD
4677
CYCN
Cyclerion Therapeutics, Inc. - Common Stock
3.83 USD-1.29%+15.02%+21.59%+20.44%16.59 M USD

Frequently asked questions about Pluri Inc. - Common Stock

What is the Pluri Inc. - Common Stock stock price today?

The current price of Pluri Inc. - Common Stock (PLUR) is 1.6800000000000002. Over the past 24 hours, the stock has changed by +3.07%. Follow the PLUR chart for real-time price dynamics.

What is the stock ticker of Pluri Inc. - Common Stock?

Pluri Inc. - Common Stock trades under the ticker PLUR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Pluri Inc. - Common Stock stock going up?

PLUR has changed by -16.42% over the last week, -26.96% over the last month, and -56.04% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Pluri Inc. - Common Stock net income for the last quarter?

Pluri Inc. - Common Stock reported net income of -5.55 M for the last quarter. The previous quarter showed -6.54 M, which means net income changed by +15.21%.

How many employees does Pluri Inc. - Common Stock have?

As of the latest available data, Pluri Inc. - Common Stock has 142 employees. Workforce size can provide additional context about the company's scale and operations.

What is Pluri Inc. - Common Stock EBITDA?

Pluri Inc. - Common Stock EBITDA is -2.53 M, and its EBITDA margin is -1 514.37%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Pluri Inc. - Common Stock stock?

You can buy Pluri Inc. - Common Stock (PLUR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Pluri Inc. - Common Stock stock?

Investing in Pluri Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PLUR chart and related analysis on metatrader.com as part of your research.

Pluri Inc. - Common Stock

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.

News